Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroko Usami is active.

Publication


Featured researches published by Hiroko Usami.


Immunopharmacology | 1986

Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.

Akihiro Yamamoto; Masahiro Nagamuta; Hiroko Usami; Yutaka Sugawara; Naoki Watanabe; Yoshihiro Niitsu; Ichiro Urushizaki

A cytotoxic factor was induced in peritoneal fluid by injection of OK-432 in mice which had been primed with OK-432. Two-step stimulation (priming and eliciting) was always necessary to induce the cytotoxic factor. OK-432-primed mice did not produce soluble cytotoxic factor spontaneously and no cytotoxic activity was detected in the mice treated by a single injection of OK-432 as an eliciting agent. This observation was also confirmed by in vitro experiments. Only when activated macrophages were incubated with OK-432 (or with lipopolysaccharide) was cytotoxin released into medium supernatant. High doses of OK-432 were required to prime mice for the production of cytotoxic factor, whereas a small amount was enough to elicit. The peritoneal cytotoxic factor obtained by OK-432 injection appears to be identical to tumor necrosis factor in the serum for the following reasons: The two factors are similar in mode of cytotoxic action. Both are produced from macrophages. They are similar in physicochemical characteristics. The cytotoxicity of the peritoneal cytotoxic factor was totally abolished by anti-TNF serum.


British Journal of Cancer | 1985

The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis

Akihiro Yamamoto; Hiroko Usami; M. Nagamuta; Y. Sugawara; S. Hamada; T. Yamamoto; K. Kato; S. Kokeguchi; S. Kotani

The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis


British Journal of Cancer | 1988

Antitumour effects of streptococcal lipoteichoic acids on Meth A fibrosarcoma.

Hiroko Usami; Akihiro Yamamoto; W. Yamashita; Y. Sugawara; S. Hamada; T. Yamamoto; K. Kato; S. Kokeguchi; H. Ohokuni; S. Kotani

The antitumour effects of lipoteichoic acids (LTA) extracted from Streptococcus pyogenes were studied in comparison with other streptococcal cellular components. LTA suppressed the tumour growth of both solid- and ascites-type Meth A fibrosarcoma as did the whole cells of S. pyogenes (OK-432). No other cellular components, such as cell wall peptidoglycan, group-specific C-carbohydrate or type-specific M protein, suppressed the growth of Meth A. LTA, but not the other cellular components, induced tumour necrosis factor (TNF) in Propionibacterium acnes-primed mice. LTA had no direct killing effects on Meth A cells. These results indicate that LTA may be an important antitumour component of OK-432 and that one of the antitumour mechanisms by this streptococcal preparation is the induction of TNF.


Microbiology and Immunology | 1987

Possible existence of a novel amphipathic immunostimulator in the phenol-water extracts of mycobacteriaceae

Takako Ikeda-Fujita; Shozo Kotani; Masachika Tsujimoto; Tomohiko Ogawa; Ichiro Takahashi; Haruhiko Takada; Hidetoshi Shimauchi; Shigeki Nagao; Susumu Kokeguchi; Keijiro Kato; Ikuya Yano; Haruki Okamura; Toshishide Tamura; Kazuhiro Harada; Hiroko Usami; Akihiko Yamamoto; Shigenori Tanaka; Yoshiko Kato

The extracts having diverse immunostimulating activities were obtained as a water‐phase fraction from four bacterial species representing the 4 genera (Mycobacterium, Nocardia, Gordona, and Rhodococcus) of Mycobacteriaceae by the phenol‐water method, which is commonly used for extraction of endotoxic lipopolysaccharides (LPS) from gram‐negative bacteria and amphipathic substances from gram‐positives. These fractions, especially those of G. aurantiaca and R. terrae, showed strong stimulatory effects on murine splenocytes, macrophages of mice and guinea pigs, the immunoadjuvant activities in guinea pigs and mice, and the distinct activities inducing a tumor necrosis factor and interferons α/β and γ in primed mice. The fractions from G. aurantiaca and R. terrae exhibited potent pyrogenicity and the ability to activate the clotting enzyme cascade of the horseshoe crab (Tachypleus tridentatus). Some of these biological activities were not very different from the potency of the reference endotoxic LPS derived from Escherichia coli or Fusobacterium nucleatum. But the test fractions neither showed the activity to prepare rabbit skin to the local Shwartzman reaction, nor reacted with anti‐lipid A conventional and monoclonal antibodies. Furthermore, unlike LPS, these fractions stimulated the splenocytes of C3H/HeJ mice (LPS‐Nonresponder). Although the fractions showing the above biological activities have not yet been adequately purified, they contained polysaccharides, whose main constituent sugar is mannose with a smaller amount of arabinose, fatty acids consisting primarily of palmitic, stearic, and tuberculostearic acids, and small amounts of peptides and amino sugars. Since components characteristic of known immunomodulators of bacterial origin, namely endotoxins (lipid As), cell wall peptidoglycans, lipoteichoic acids, cord factors (trehalose dimycolates), or deoxyribonucleic acids, were practically not detected in these fractions, the agent responsible for the above bioactivities is considered to be a novel substance different from the known, bacterial immunomodulators.


Immunology Letters | 1985

Production of cytotoxic factor into mouse peritoneal fluid by OK-432, a streptococcal preparation

Akihiro Yamamoto; Masahiro Nagamuta; Hiroko Usami; Yutaka Sugawara; Naoki Watanabe; Yoshiro Niitsu; Ichiro Urushizaki

A cytotoxic factor was induced by the injection of LPS into the peritoneal fluids of mice which had been previously primed with a streptococcal antitumor preparation, OK-432. No cytotoxic effect on L-929 cells was observed in the peritoneal fluids of mice singly treated with OK-432 or LPS. Various mouse and human tumor cell lines were effectively killed by this peritoneal cytotoxic factor, though normal cell lines were insensitive, which indicates that this factor is not species-specific. The highest level of cytotoxic activity was obtained when LPS was given to mice 5 days after the injection of OK-432. The optimal time for collection of peritoneal fluids for the cytotoxic factor was 2 h following the LPS injection. Interferon activity was found to be negative by the plaque reduction test using L-929 cells with vesicular stomatitis virus. These results suggest that this cytotoxic factor is similar to the tumor necrosis factor (TNF) in the mouse serum.


Immunology Letters | 1986

Characterization of a cytotoxic factor induced in mouse peritoneal fluid by OK-432☆

Masahiro Nagamuta; Akihiro Yamamoto; Hiroko Usami; Yutaka Sugawara; Naoki Watanabe; Yoshiro Niitsu; Ichiro Urushizaki

A cytotoxic factor (peritoneal cytotoxic factor, PCF) was strongly induced by the injection of LPS into the peritoneal fluids of mice which had been previously primed with OK-432. In order to clarify characteristics of PCF, physicochemical and immunological studies were conducted. When incubated with LPS, the macrophages from mice primed with OK-432 induced PCF whereas the lymphocytes did not. These results indicate that PCF is different from lymphotoxin. PCF appears to be quite similar to tumor necrosis factor (TNF) in the serum for the following reasons: The two factors are similar in the mode of cytotoxic action in vitro; both factors have a tumor necrotizing effect when injected into tumor bearing mice; both are produced from macrophages; they are similar in physicochemical characteristics; and the cytotoxic activity of PCF is totally abolished by anti-TNF serum.


British Journal of Cancer | 1987

A nontoxic tumour necrosis factor induced by streptococcal lipoteichoic acids.

Hiroko Usami; Akihiro Yamamoto; Y. Sugawara; S. Hamada; T. Yamamoto; K. Kato; S. Kokeguchi; H. Takada; S. Kotani


Archive | 1979

Anti-tumor substance and process for preparing the same

Yutaka Sugawara; Akihiro Yamamoto; Mitsuaki Handa; Hiroko Usami; Haruki Ogawa


Archive | 1986

Tumor necrosis factor inducing substance derived from acid-fast bacteria

Yoshiko Kato; Hiroko Usami


Archive | 1984

Antitumormittel. Anti-tumor agents.

Hiroko Usami; Akihiro Yamamoto; Yutaka Sugawara; Shozo Kotani; Keijiro Kato

Collaboration


Dive into the Hiroko Usami's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yutaka Sugawara

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

K. Kato

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Naoki Watanabe

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

S. Hamada

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

S. Kotani

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

T. Yamamoto

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Y. Sugawara

Chugai Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge